Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program — Stella

Recruiting

Back to HIV Prevention trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

University of Washington, Seattle, Washington

Key details

Sponsor

University of Washington

Collaborators

Tasso Inc.

Enrollment target

~458 participants

Started

March 2022

Primary completion

March 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov